A detailed history of M&G Investment Management LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, M&G Investment Management LTD holds 120,407 shares of GILD stock, worth $7.74 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
120,407
Previous 120,407 -0.0%
Holding current value
$7.74 Million
Previous $9.75 Billion -0.0%
% of portfolio
0.03%
Previous 0.03%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$73.27 - $83.09 $486,219 - $551,385
-6,636 Reduced 5.22%
120,407 $9.75 Billion
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $367,112 - $400,526
4,965 Added 4.07%
127,043 $9.53 Billion
Q2 2023

Aug 01, 2023

BUY
$76.01 - $86.7 $6.72 Million - $7.66 Million
88,397 Added 262.45%
122,078 $9.4 Billion
Q1 2023

May 11, 2023

SELL
$77.31 - $88.08 $3 Million - $3.42 Million
-38,780 Reduced 53.52%
33,681 $2.79 Million
Q4 2022

Jan 27, 2023

BUY
$62.32 - $89.47 $102,080 - $146,551
1,638 Added 2.31%
72,461 $0
Q3 2022

Nov 01, 2022

SELL
$59.54 - $68.01 $16,968 - $19,382
-285 Reduced 0.4%
70,823 $4.39 Million
Q2 2022

Aug 25, 2022

BUY
$57.72 - $65.01 $6,406 - $7,216
111 Added 0.16%
71,108 $4.41 Million
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $225,135 - $282,118
3,887 Added 5.79%
70,997 $4.19 Million
Q4 2021

Jan 18, 2022

SELL
$64.88 - $73.64 $14.3 Million - $16.2 Million
-219,826 Reduced 76.61%
67,110 $4.9 Million
Q3 2021

Nov 09, 2021

BUY
$67.69 - $73.03 $74,188 - $80,040
1,096 Added 0.38%
286,936 $20 Million
Q2 2021

Aug 16, 2021

BUY
$63.47 - $69.35 $11.7 Million - $12.8 Million
184,538 Added 182.17%
285,840 $19.7 Million
Q1 2021

May 12, 2021

SELL
$60.0 - $68.46 $1.11 Million - $1.27 Million
-18,545 Reduced 15.47%
101,302 $6.59 Million
Q4 2020

Feb 02, 2021

SELL
$56.65 - $64.55 $791,343 - $901,698
-13,969 Reduced 10.44%
119,847 $6.95 Million
Q3 2020

Oct 26, 2020

SELL
$62.1 - $78.08 $315,033 - $396,099
-5,073 Reduced 3.65%
133,816 $8.43 Million
Q2 2020

Jul 22, 2020

BUY
$72.34 - $84.0 $6.53 Million - $7.59 Million
90,322 Added 185.97%
138,889 $10.7 Million
Q1 2020

Apr 09, 2020

SELL
$62.63 - $80.22 $875,316 - $1.12 Million
-13,976 Reduced 22.35%
48,567 $3.64 Million
Q4 2019

Jan 28, 2020

BUY
$61.62 - $67.78 $3.85 Million - $4.24 Million
62,543 New
62,543 $4.07 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $80.6B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.